Current Chairman of the Board of Directors Former Executive Chairman of the Board of Directors, and Former President and Chief Executive Officer · TANDEM DIABETES CARE INC (TNDM)

Kim Blickenstaff

A named executive officer of TANDEM DIABETES CARE in every fiscal year CompBrief holds from FY2016 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$10,544,957

Salary $500,000Stock awards $0

FY2018: $2,983,485

2nd of 6 named executive officers at Tandem Diabetes Care by FY2019 total.

6 named officers on file for TANDEM DIABETES CARE, FY2019

Kim Blickenstaff’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • TNDM’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how TANDEM DIABETES CARE’s whole pay program stands against its peers

  • TANDEM DIABETES CARE’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TNDM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 15, 2020 (DEF 14A).

Free

Get Kim Blickenstaff’s full pay file as a PDF — free

More than this page: up to 10 years of Kim’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Kim Blickenstaff compensation by year

TANDEM DIABETES CARE Summary Compensation Table · all 4 fiscal years held
In US dollars, as TANDEM DIABETES CARE reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019
Salary$569,006$583,495$1$500,000
Bonus$0$0$0$0
Stock awards$0$0$0$0
Option awards$866,656$160,338$2,395,065$9,243,268
Non-equity incentive$0$0$583,495$796,792
Pension and deferred compensation$0$0$0$0
All other$2,772$5,334$4,924$4,897
Total$1,438,434$749,167$2,983,485$10,544,957

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TANDEM DIABETES CARE INC DEF 14A filed April 15, 2020, accession 0001438133-20-000032, and prior-year filings.

How this page was built: the TANDEM DIABETES CARE INC filed document, accession 0001438133-20-000032. Every figure is read from that document and cited to the page and table it appears in. Filed April 15, 2020.

$1.4M
$749K
$3.0M
$10.5M
FY16
FY17
FY18
FY19
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option50,000—$18.86
Option11,152—$9.00
Option986—$69.50
Option210,000—$51.50

Per the Outstanding Equity Awards at Fiscal Year-End table in TANDEM DIABETES CARE INC's FY2019 proxy; value at the fiscal year-end close, as the company printed it.

TANDEM DIABETES CARE’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
John SheridanPresident and Chief Executive Officer$10,560,937
Kim Blickenstaff · this pageCurrent Chairman of the Board of Directors Former Executive Chairman of the Board of Directors, and Former President and Chief Executive Officer$10,544,957
Brian HansenExecutive Vice President, Chief Commercial Officer$5,399,897
Leigh VossellerExecutive Vice President, Chief Financial Officer and Treasurer$5,391,452
David BergerExecutive Vice President, Chief Legal and Compliance Officer & Corporate Secretary (5)$5,390,888
Susan MorrisonExecutive Vice President, Chief Administrative Officer$5,390,241

Board service

TANDEM DIABETES CARE board · FY2021–FY2023
Director compensation in US dollars, as TANDEM DIABETES CARE reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2023$73,833$124,950——$198,783
FY2022$130,083$179,977——$310,060
FY2021$164,667$179,994——$344,661

Each year as the company reported it in TANDEM DIABETES CARE's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: TANDEM DIABETES CARE pays directors a $60,000 cash retainer and $180,000 in equity. As stated in TANDEM DIABETES CARE's FY2025 proxy.

The full TANDEM DIABETES CARE compensation record

free company brief

This page is one person within TANDEM DIABETES CARE's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the TANDEM DIABETES CARE proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are TANDEM DIABETES CARE's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kim Blickenstaff's compensation dossier · One-time report. No refunds.